Erik van Kaathoven

Erik van Kaathoven

Erik van Kaathoven on LinkedIn

Chief Financial Officer

Over 20 years of experience in management consulting, private equity, corporate finance and executive management of technology, life sciences and business services companies. As a strategy consultant, Erik advised Big Pharma on market entry stategies for new drugs. He was involved with early stage life sciences investments across Europe as a Partner at Swiss VC firm Metellus and as Venture Partner in technology incubator Antfactory.

He is also a partner at VK Partners, a venture acceleration firm, which specialises in commercialising early stage technology and life science ventures.

Prior roles include: Partner of Metellus, board member of several of its ventures in Europe and USA. COO of Rebus, a global software firm backed by Warburg Pincus and General Atlantic. MD Business Services of FTSE listed Xchanging plc, a global outsourcing business (now a part of CSC). Strategy consultant at Monitor Company.

Erik holds masters degrees in Applied Physics and Business from Delft University of Technology, and studied Leading Change & Organisational Renewal at Stanford Graduate School of Business